BR0308523A - Método de administração de um antibiótico injetável à orelha de um animal - Google Patents

Método de administração de um antibiótico injetável à orelha de um animal

Info

Publication number
BR0308523A
BR0308523A BR0308523-6A BR0308523A BR0308523A BR 0308523 A BR0308523 A BR 0308523A BR 0308523 A BR0308523 A BR 0308523A BR 0308523 A BR0308523 A BR 0308523A
Authority
BR
Brazil
Prior art keywords
animal
ear
administration
antibiotic
injectable antibiotic
Prior art date
Application number
BR0308523-6A
Other languages
English (en)
Inventor
Scott A Brown
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28454766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308523(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR0308523A publication Critical patent/BR0308523A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"MéTODO DE ADMINISTRAçãO DE UM ANTIBIóTICO INJETáVEL A ORELHA DE UM ANIMAL". é revelado um método de administração de um antibiótico a um animal que dele necessite, incluindo a etapa de injetar o antibiótico de forma subcutânea na junção de uma aurícula com o crânio do animal.
BR0308523-6A 2002-03-21 2003-03-19 Método de administração de um antibiótico injetável à orelha de um animal BR0308523A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36621202P 2002-03-21 2002-03-21
PCT/US2003/008571 WO2003079923A1 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to the ear of an animal

Publications (1)

Publication Number Publication Date
BR0308523A true BR0308523A (pt) 2005-02-01

Family

ID=28454766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308523-6A BR0308523A (pt) 2002-03-21 2003-03-19 Método de administração de um antibiótico injetável à orelha de um animal

Country Status (15)

Country Link
US (3) US20030181398A1 (pt)
EP (1) EP1485040B2 (pt)
JP (1) JP4365222B2 (pt)
KR (1) KR20040097187A (pt)
CN (1) CN1635856A (pt)
AT (1) ATE343980T1 (pt)
AU (1) AU2003230697B2 (pt)
BR (1) BR0308523A (pt)
CA (1) CA2476327A1 (pt)
DE (1) DE60309447T3 (pt)
ES (1) ES2275092T5 (pt)
IL (1) IL164158A0 (pt)
MX (1) MXPA04009177A (pt)
WO (1) WO2003079923A1 (pt)
ZA (1) ZA200406501B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107982214B (zh) * 2016-10-26 2021-02-05 华中农业大学 兽用恩诺沙星固体脂质纳米混悬液及其制备方法
EP3558284A2 (en) 2016-12-23 2019-10-30 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
EP3558939A1 (en) 2016-12-23 2019-10-30 Intervet International B.V. Compounds useful for treating a mannheimia haemolytica or histophilus somni infection
CN107802613B (zh) * 2017-11-13 2020-01-31 郑州大学 一种掩味肠道速释型替米考星微纳米干混悬剂及其制备方法
US20210292284A1 (en) * 2018-06-25 2021-09-23 Intervet Inc. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni
WO2020002238A1 (en) 2018-06-25 2020-01-02 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
CN109077999A (zh) * 2018-08-31 2018-12-25 田红卫 一种长效缓释替米考星注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883984A (en) * 1957-09-09 1959-04-28 Pfizer & Co C Pellet implanter
US2999020A (en) * 1959-06-09 1961-09-05 Hodges Res & Dev Co Processes for the tendering of meat
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
EP0386000B1 (en) * 1987-07-29 1992-03-11 The Upjohn Company Controlled release of antibiotic salts from an implant
ZA889601B (en) * 1987-09-23 1989-10-25 Petrus Burger Andries A composition for use in treating animals
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
SK283674B6 (sk) † 1993-03-12 2003-11-04 Pharmacia & Upjohn Company Kryštalická voľná kyselina ceftiofuru a spôsob jej prípravy a farmaceutická kompozícia, ktorá ju obsahuje
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
US20030181398A1 (en) 2003-09-25
CA2476327A1 (en) 2003-10-02
KR20040097187A (ko) 2004-11-17
DE60309447D1 (de) 2006-12-14
DE60309447T2 (de) 2007-03-29
CN1635856A (zh) 2005-07-06
JP2005520624A (ja) 2005-07-14
WO2003079923A1 (en) 2003-10-02
ZA200406501B (en) 2005-06-21
US8968759B2 (en) 2015-03-03
IL164158A0 (en) 2005-12-18
DE60309447T3 (de) 2020-04-23
ATE343980T1 (de) 2006-11-15
EP1485040B1 (en) 2006-11-02
US20150182454A1 (en) 2015-07-02
AU2003230697A1 (en) 2003-10-08
JP4365222B2 (ja) 2009-11-18
ES2275092T5 (es) 2020-06-17
US20110098266A1 (en) 2011-04-28
MXPA04009177A (es) 2004-12-07
AU2003230697B2 (en) 2008-07-17
EP1485040A1 (en) 2004-12-15
EP1485040B2 (en) 2019-12-11
ES2275092T3 (es) 2007-06-01

Similar Documents

Publication Publication Date Title
ATE442862T2 (de) Niederviskose konzentrierte proteinformulierungen
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
WO2004056305A3 (en) Administration of capsaicinoids
EP4324426A3 (en) Dental devices and systems and methods for making the same
DK1565471T3 (da) Quionolinylpyrazoler
DE60111967D1 (de) Nadelloses Subkutaninjektionssystem
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
ATE244558T1 (de) Trockene formbare arzneistoffformulierung
EA200101089A1 (ru) Новый способ лечения
WO2005009287A3 (en) Drug delivery to the inner ear and methods of using same
ES2213707T3 (es) Estimulacion del crecimiento oseo con un derivado peptidico de la trombina.
AR034371A1 (es) Composiciones farmaceuticas
DK0998287T3 (da) Anvendelse af levobupivacain
BR0308523A (pt) Método de administração de um antibiótico injetável à orelha de um animal
EA200001010A1 (ru) Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии
ATE448750T1 (de) Zahnwurzelkanalverankerungsanordnung
NO20051261L (no) Morfin-6-glukuronidsalt
TW200500070A (en) Method of improved diuresis in individuals with impaired renal function
IL164195A0 (en) Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
CA2381095A1 (en) Method for treating insulin resistance through hepatic nitric oxide
MY142646A (en) Chemokine receptor antagonists and methods of use therefor
ATE402662T1 (de) Ästhetisches endosteales implantat
UA46682A (uk) Спосіб зняття потягу до алкоголю, у тому числі без бажання та згоди пацієнта
AP2000001959A0 (en) Treatment of generalized anxiety disorder with paroxetine.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: PAH PANDU LLC (US)

B25D Requested change of name of applicant approved

Owner name: ZOETIS PANDU LLC (US)

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61D 7/00 , A61K 31/545 , A61K 9/08

Ipc: A61K 31/545 (2006.01), A61K 9/08 (2006.01), A61D 7

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 E 32 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: ZOETIS SERVICES LLC (US)